Pulmonary fibrosis (PF), or idiopathic pulmonary fibrosis (IPF) when physicians are unable to identify the cause of the disease, affects the respiratory system by the thickening and stiffening of lung tissue, leaving scar tissue in the process. There is no single test to diagnose PF, and a battery of diagnostic tests is often required to reach an accurate diagnosis.

These diagnostic tests include chest X-rays, high-resolution computed tomography (HRCT) scans, pulse oximetry tests, arterial blood gas tests, and electrocardiograms (ECG).

An ECG is a simple, painless procedure that detects your heart’s electrical activity. An ECG can show how fast your heart is beating, whether the rhythm is steady or irregular, and the strength and regularity of the electrical impulses.

An ECG may be recorded in a doctor’s office, an outpatient facility, in the hospital or as part of stress testing. There are three main types of ECG:

  • Resting ECG: If the main interest is to measure how your heart is working while resting, you will be asked to lie down and relax while the heartbeat is being recorded.
  • Exercise ECG: If the doctor’s main interest is to measure how your heart reacts to activity, you will be asked to walk or run on a treadmill or cycle on an exercise bike while your heartbeat is recorded.
  • 24-hour ECG: If the main interest is to monitor your heartbeat throughout the day, you will be asked to wear a small electrocardiograph device for a day and then return to your doctor’s office so they can read the results.

To diagnose PF and IPF, patients are usually asked to have the exercise ECG, where patients are asked to walk or pedal for a few minutes to reveal how the lungs move oxygen and carbon dioxide in and out of the bloodstream.

This type is preferred to check your heart rate, your blood pressure, and, together with a pulse oximeter, the amount of oxygen in your blood. During the test, your doctor might place a catheter (a small flexible tube) in an artery in one of your arms to draw blood samples. These will provide a more precise measure of how oxygen and carbon dioxide levels vary in your bloodstream.

Note: Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. 

Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Total Posts: 110
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
×
Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Latest Posts
  • Fat-free mass index
  • acute exacerbation
  • lung function test
  • lung disease treatment